| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC19P H2BC12 | 1.38e-12 | 100 | 94 | 11 | GO:0030527 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | VAPA H2BC11 SIM2 ZHX2 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC19P SNX2 H2BC12 | 5.31e-10 | 398 | 94 | 15 | GO:0046982 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.00e-06 | 5 | 94 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | structural molecule activity | RPL23A H2BC11 H2BC18 JPH1 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AHNAK MYOM2 H2BC19P H2BC12 MYBPC3 | 3.78e-06 | 891 | 94 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | protein dimerization activity | VAPA H2BC11 SIM2 ZHX2 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 HPD H2BC19P DGCR8 SNX2 H2BC12 | 4.22e-05 | 1205 | 94 | 17 | GO:0046983 |
| GeneOntologyMolecularFunction | selenocysteine insertion sequence binding | 3.25e-04 | 6 | 94 | 2 | GO:0035368 | |
| GeneOntologyBiologicalProcess | innate immune response in mucosa | 3.88e-09 | 30 | 93 | 6 | GO:0002227 | |
| GeneOntologyBiologicalProcess | mucosal immune response | 7.52e-08 | 48 | 93 | 6 | GO:0002385 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 7.95e-08 | 122 | 93 | 8 | GO:0006334 | |
| GeneOntologyBiologicalProcess | organ or tissue specific immune response | 1.55e-07 | 54 | 93 | 6 | GO:0002251 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 2.57e-07 | 142 | 93 | 8 | GO:0034728 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 2.34e-06 | 85 | 93 | 6 | GO:0019731 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 2.48e-06 | 134 | 93 | 7 | GO:0061844 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 1.70e-05 | 249 | 93 | 8 | GO:0065004 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 2.13e-05 | 186 | 93 | 7 | GO:0019730 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum localization | 2.46e-05 | 13 | 93 | 3 | GO:0051643 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 6.06e-05 | 150 | 93 | 6 | GO:0050830 | |
| GeneOntologyBiologicalProcess | biological phase | 9.58e-05 | 53 | 93 | 4 | GO:0044848 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2BC11 CHD9 JARID2 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF BRD4 SPTY2D1 | 1.23e-04 | 741 | 93 | 12 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | H2BC11 CHD9 SRPK1 JARID2 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF BRD4 SPTY2D1 | 1.87e-04 | 896 | 93 | 13 | GO:0006325 |
| GeneOntologyBiologicalProcess | hair follicle maturation | 2.98e-04 | 29 | 93 | 3 | GO:0048820 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum-plasma membrane tethering | 2.98e-04 | 6 | 93 | 2 | GO:0061817 | |
| GeneOntologyCellularComponent | nucleosome | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC19P H2BC12 | 3.00e-11 | 138 | 94 | 11 | GO:0000786 |
| GeneOntologyCellularComponent | chromatin | H2BC11 SRPK1 SIM2 ZHX2 ADNP H2BC18 H2BC12L MSX2 JARID2 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NFIB BRD4 H2BC19P H2BC12 NOBOX | 7.53e-06 | 1480 | 94 | 20 | GO:0000785 |
| GeneOntologyCellularComponent | cell leading edge | 8.40e-05 | 500 | 94 | 10 | GO:0031252 | |
| GeneOntologyCellularComponent | manchette | 2.66e-04 | 28 | 94 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | ruffle | 3.37e-04 | 206 | 94 | 6 | GO:0001726 | |
| GeneOntologyCellularComponent | dense fibrillar component | 4.14e-04 | 7 | 94 | 2 | GO:0001651 | |
| Domain | H2B | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC20P H2BC19P H2BC12 | 1.24e-20 | 21 | 96 | 11 | SM00427 |
| Domain | HISTONE_H2B | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC20P H2BC19P H2BC12 | 1.24e-20 | 21 | 96 | 11 | PS00357 |
| Domain | Histone_H2B | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC20P H2BC19P H2BC12 | 1.24e-20 | 21 | 96 | 11 | IPR000558 |
| Domain | Histone | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC20P H2BC19P H2BC12 | 4.51e-15 | 56 | 96 | 11 | PF00125 |
| Domain | Histone_H2A/H2B/H3 | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC20P H2BC19P H2BC12 | 4.51e-15 | 56 | 96 | 11 | IPR007125 |
| Domain | Histone-fold | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC20P H2BC19P H2BC12 | 4.37e-13 | 83 | 96 | 11 | IPR009072 |
| Domain | - | 2.34e-09 | 69 | 96 | 8 | 1.10.20.10 | |
| Domain | FN3 | 8.58e-06 | 199 | 96 | 8 | PS50853 | |
| Domain | FN3_dom | 1.23e-05 | 209 | 96 | 8 | IPR003961 | |
| Domain | FN3 | 4.74e-05 | 185 | 96 | 7 | SM00060 | |
| Domain | - | MYLK MYCBP2 FGFRL1 SIRPA ITGB4 RIMBP3 PTPRG RIMBP3C MYOM2 RIMBP3B MYBPC3 | 5.92e-04 | 663 | 96 | 11 | 2.60.40.10 |
| Domain | - | 7.17e-04 | 8 | 96 | 2 | 2.60.40.360 | |
| Domain | Calx_beta | 9.19e-04 | 9 | 96 | 2 | IPR003644 | |
| Domain | PapD-like | 9.19e-04 | 9 | 96 | 2 | IPR008962 | |
| Domain | Calx-beta | 9.19e-04 | 9 | 96 | 2 | PF03160 | |
| Domain | Ig-like_fold | MYLK MYCBP2 FGFRL1 SIRPA ITGB4 RIMBP3 PTPRG RIMBP3C MYOM2 RIMBP3B MYBPC3 | 9.91e-04 | 706 | 96 | 11 | IPR013783 |
| Pathway | REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS | H2BC11 SRPK1 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.76e-15 | 42 | 65 | 10 | M48029 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | H2BC11 H2BC12L JARID2 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 9.04e-13 | 72 | 65 | 10 | M27132 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.85e-12 | 55 | 65 | 9 | M29526 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 8.87e-12 | 62 | 65 | 9 | M27700 |
| Pathway | REACTOME_DNA_METHYLATION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.20e-11 | 64 | 65 | 9 | M27429 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC11 SRPK1 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 NOBOX | 1.32e-11 | 128 | 65 | 11 | M48019 |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.60e-11 | 66 | 65 | 9 | M27488 |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.84e-11 | 67 | 65 | 9 | M27342 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.84e-11 | 67 | 65 | 9 | M39003 |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.11e-11 | 68 | 65 | 9 | M27658 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.11e-11 | 68 | 65 | 9 | M27587 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.76e-11 | 70 | 65 | 9 | M48261 |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.76e-11 | 70 | 65 | 9 | M48028 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 3.59e-11 | 72 | 65 | 9 | M29714 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 4.08e-11 | 73 | 65 | 9 | M27166 |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 5.24e-11 | 75 | 65 | 9 | M27343 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | H2BC11 GGA3 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 6.91e-11 | 110 | 65 | 10 | M27958 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 7.53e-11 | 78 | 65 | 9 | M1061 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 7.53e-11 | 78 | 65 | 9 | M27589 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 8.47e-11 | 79 | 65 | 9 | M27191 |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | H2BC11 MYLK CKAP5 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DYNC1LI1 PAK3 CDC20 H2BC12 | 1.77e-10 | 323 | 65 | 14 | M27080 |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF H2BC12 | 1.94e-10 | 122 | 65 | 10 | M29689 |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.28e-10 | 88 | 65 | 9 | M1011 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.52e-10 | 89 | 65 | 9 | M27943 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.79e-10 | 90 | 65 | 9 | M2158 |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.79e-10 | 90 | 65 | 9 | M27691 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.79e-10 | 90 | 65 | 9 | M29668 |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 3.09e-10 | 91 | 65 | 9 | M27101 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 3.76e-10 | 93 | 65 | 9 | M27487 |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 4.15e-10 | 94 | 65 | 9 | M1080 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2BC11 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 4.15e-10 | 94 | 65 | 9 | M27230 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 5.02e-10 | 96 | 65 | 9 | M27792 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 5.51e-10 | 97 | 65 | 9 | M48262 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 5.51e-10 | 97 | 65 | 9 | M27590 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2BC11 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DYNC1LI1 H2BC12 | 6.59e-10 | 138 | 65 | 10 | M29805 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DGCR8 H2BC12 | 7.07e-10 | 139 | 65 | 10 | M715 |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.03e-09 | 104 | 65 | 9 | M29829 |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.13e-09 | 105 | 65 | 9 | M27425 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.23e-09 | 106 | 65 | 9 | M27458 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.33e-09 | 107 | 65 | 9 | M48260 |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.45e-09 | 108 | 65 | 9 | M27426 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.71e-09 | 110 | 65 | 9 | M27696 |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.85e-09 | 111 | 65 | 9 | M27187 |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.01e-09 | 112 | 65 | 9 | M48334 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.01e-09 | 112 | 65 | 9 | M4052 |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2BC11 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.75e-09 | 116 | 65 | 9 | M29806 |
| Pathway | REACTOME_HCMV_INFECTION | H2BC11 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DYNC1LI1 H2BC12 | 3.16e-09 | 162 | 65 | 10 | M29804 |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 3.45e-09 | 119 | 65 | 9 | M607 |
| Pathway | REACTOME_MEIOSIS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 3.71e-09 | 120 | 65 | 9 | M529 |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 5.33e-09 | 125 | 65 | 9 | M27186 |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 7.05e-09 | 129 | 65 | 9 | M27795 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | H2BC11 CKAP5 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DYNC1LI1 CDC20 H2BC12 | 7.25e-09 | 291 | 65 | 12 | M16647 |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 8.98e-09 | 59 | 65 | 7 | M27763 | |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2BC11 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.36e-08 | 139 | 65 | 9 | M4741 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.36e-08 | 139 | 65 | 9 | M868 |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.45e-08 | 140 | 65 | 9 | M27584 |
| Pathway | REACTOME_MITOTIC_PROPHASE | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.64e-08 | 142 | 65 | 9 | M27660 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.64e-08 | 142 | 65 | 9 | M48257 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.64e-08 | 142 | 65 | 9 | M27233 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | H2BC11 ARHGAP24 MYLK ESYT1 CKAP5 ANKRD26 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DYNC1LI1 PAK3 CDC20 H2BC12 | 1.69e-08 | 720 | 65 | 17 | M41838 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.49e-08 | 149 | 65 | 9 | M27888 |
| Pathway | REACTOME_REPRODUCTION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 4.15e-08 | 158 | 65 | 9 | M26956 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 4.39e-08 | 159 | 65 | 9 | M27665 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2BC11 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CDC20 H2BC12 | 6.17e-08 | 221 | 65 | 10 | M27578 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 6.71e-08 | 167 | 65 | 9 | M19381 |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 7.10e-08 | 79 | 65 | 7 | M27742 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 7.82e-08 | 170 | 65 | 9 | M27582 |
| Pathway | REACTOME_DNA_REPLICATION | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.77e-07 | 187 | 65 | 9 | M1017 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2BC11 H2BC12L JARID2 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.27e-07 | 254 | 65 | 10 | M27131 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.75e-07 | 197 | 65 | 9 | M27188 |
| Pathway | REACTOME_M_PHASE | H2BC11 CKAP5 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DYNC1LI1 CDC20 H2BC12 | 3.74e-07 | 417 | 65 | 12 | M27662 |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 6.98e-07 | 220 | 65 | 9 | M27794 |
| Pathway | REACTOME_DEUBIQUITINATION | H2BC11 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CDC20 H2BC12 | 1.01e-06 | 299 | 65 | 10 | M27574 |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.13e-06 | 233 | 65 | 9 | M27099 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.30e-06 | 237 | 65 | 9 | M27786 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.77e-06 | 246 | 65 | 9 | M10189 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 2.11e-06 | 46 | 65 | 5 | MM14935 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 4.04e-06 | 272 | 65 | 9 | M29619 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 5.19e-06 | 55 | 65 | 5 | MM14932 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 8.01e-06 | 296 | 65 | 9 | M27869 |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | H2BC11 CKAP5 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DYNC1LI1 CDC20 H2BC12 | 8.21e-06 | 561 | 65 | 12 | M5336 |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.91e-05 | 330 | 65 | 9 | M7847 |
| Pathway | REACTOME_DNA_REPAIR | H2BC11 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.00e-05 | 332 | 65 | 9 | M15434 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 3.00e-05 | 39 | 65 | 4 | MM14850 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | RPL23A H2BC11 SRPK1 NCL H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 DYNC1LI1 H2BC12 | 4.17e-05 | 888 | 65 | 14 | M48034 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | RPL23A H2BC11 MYO5A ZNF423 CHD9 SRPK1 ITGB4 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF PAK3 H2BC12 NOBOX | 5.63e-05 | 1432 | 65 | 18 | M509 |
| Pathway | REACTOME_CELL_CYCLE | H2BC11 CKAP5 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DYNC1LI1 CDC20 H2BC12 | 6.71e-05 | 694 | 65 | 12 | M543 |
| Pathway | REACTOME_INFECTIOUS_DISEASE | RPL23A H2BC11 MYO5A SRPK1 NCL H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 DYNC1LI1 H2BC12 | 9.14e-05 | 1081 | 65 | 15 | M27548 |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | RPL23A H2BC11 CHD9 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DYNC1LI1 H2BC12 | 3.51e-04 | 828 | 65 | 12 | M27827 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 3.84e-04 | 31 | 65 | 3 | MM17225 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 6.50e-04 | 37 | 65 | 3 | MM14883 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 7.03e-04 | 38 | 65 | 3 | MM15434 | |
| Pathway | PID_AURORA_B_PATHWAY | 7.59e-04 | 39 | 65 | 3 | M14 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.08e-03 | 44 | 65 | 3 | MM15527 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 1.16e-03 | 45 | 65 | 3 | M39864 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 1.16e-03 | 45 | 65 | 3 | MM15508 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.26e-03 | 175 | 65 | 5 | MM14941 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 1.31e-03 | 47 | 65 | 3 | MM15296 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.53e-03 | 271 | 65 | 6 | MM15388 | |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 1.57e-03 | 50 | 65 | 3 | MM15308 | |
| Pubmed | Inhibition of core histones acetylation by carcinogenic nickel(II). | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC20P H2BC19P H2BC12 | 1.75e-24 | 18 | 99 | 11 | 16283522 |
| Pubmed | Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC20P H2BC19P H2BC12 | 1.75e-24 | 18 | 99 | 11 | 12757711 |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC12 | 4.08e-18 | 22 | 99 | 9 | 16713563 | |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC12 | 6.68e-18 | 23 | 99 | 9 | 16307923 | |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC12 | 1.15e-16 | 30 | 99 | 9 | 16319397 | |
| Pubmed | H2BC11 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC20P H2BC19P H2BC12 | 3.21e-16 | 77 | 99 | 11 | 12408966 | |
| Pubmed | Quantitative proteomic analysis of post-translational modifications of human histones. | 2.32e-14 | 17 | 99 | 7 | 16627869 | |
| Pubmed | H2BC11 ZMYM2 NCL NSUN2 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MICALL2 H2BC12 | 6.18e-14 | 277 | 99 | 14 | 30745168 | |
| Pubmed | 3.15e-13 | 67 | 99 | 9 | 25253489 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | H2BC11 LIMA1 ZMYM2 NCL H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AHNAK H2BC12 | 9.97e-13 | 271 | 99 | 13 | 32433965 |
| Pubmed | H2BC11 LIMA1 ARHGAP24 ACLY SRPK1 NCL NSUN2 YARS1 H2BC18 H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC12 | 3.12e-12 | 451 | 99 | 15 | 36168627 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | LIMA1 MYCBP2 ESYT1 CKAP5 ANKRD26 PITPNC1 NHSL1 KSR1 H2BC13 MAST4 AHNAK BRD4 NAV2 COBL CDC20 FGD6 SNX2 FAM110B AHNAK2 | 4.15e-12 | 861 | 99 | 19 | 36931259 |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC20P H2BC19P H2BC12 | 1.64e-11 | 203 | 99 | 11 | 16916647 |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | 2.34e-11 | 69 | 99 | 8 | 11689053 | |
| Pubmed | VAPA RPL23A H2BC11 NCL YARS1 H2BC18 H2BC12L YTHDF1 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AHNAK H2BC20P H2BC19P H2BC12 | 2.84e-11 | 844 | 99 | 18 | 25963833 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | VAPA RPL23A H2BC11 LIMA1 MYO5A NCL H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AHNAK H2BC12 | 2.85e-11 | 626 | 99 | 16 | 33644029 |
| Pubmed | 3.73e-11 | 73 | 99 | 8 | 14657027 | ||
| Pubmed | 3.73e-11 | 73 | 99 | 8 | 9566873 | ||
| Pubmed | 7.69e-11 | 11 | 99 | 5 | 15197225 | ||
| Pubmed | Histone modifications associated with somatic hypermutation. | 7.69e-11 | 11 | 99 | 5 | 16039583 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | RPL23A H2BC11 LIMA1 ACLY NCL H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 AHNAK H2BC12 | 9.06e-11 | 477 | 99 | 14 | 31300519 |
| Pubmed | 1.43e-10 | 86 | 99 | 8 | 11080476 | ||
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | H2BC11 NSUN2 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.97e-10 | 256 | 99 | 11 | 35777956 |
| Pubmed | VAPA H2BC11 LIMA1 ZNF423 ZNF622 NCL H2BC18 GGA3 NFIB NAV2 SECISBP2 DGCR8 | 2.29e-10 | 335 | 99 | 12 | 15741177 | |
| Pubmed | RPL23A H2BC11 ACLY NCL NSUN2 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 2.70e-10 | 425 | 99 | 13 | 21081503 | |
| Pubmed | Endotoxin-neutralizing antimicrobial proteins of the human placenta. | 3.08e-10 | 5 | 99 | 4 | 11859126 | |
| Pubmed | Biochemical and antibacterial analysis of human wound and blister fluid. | 3.08e-10 | 5 | 99 | 4 | 8620898 | |
| Pubmed | Histone H2B as a functionally important plasminogen receptor on macrophages. | 4.95e-10 | 15 | 99 | 5 | 17690254 | |
| Pubmed | VAPA RPL23A H2BC11 LIMA1 MYLK MYO5A DACT2 ANKRD26 NCL H2BC18 H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 AHNAK ANKRD30A NAV2 MLLT1 MYOM2 H2BC12 | 5.92e-10 | 1442 | 99 | 21 | 35575683 | |
| Pubmed | Gene-specific characterization of human histone H2B by electron capture dissociation. | 9.22e-10 | 6 | 99 | 4 | 16457587 | |
| Pubmed | Antimicrobial peptides in the first line defence of human colon mucosa. | 1.40e-09 | 18 | 99 | 5 | 12860195 | |
| Pubmed | 2.15e-09 | 7 | 99 | 4 | 15019208 | ||
| Pubmed | H2BC11 ACLY ESYT1 NCL NSUN2 YARS1 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 DYNC1LI1 SNX2 H2BC12 | 3.81e-09 | 878 | 99 | 16 | 37223481 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FAM193B LIMA1 ACLY ESYT1 CKAP5 ANKRD26 ZMYM2 ZNF622 NCL ADNP NSUN2 GGA3 H2BC13 CTCF AHNAK AHNAK2 | 9.09e-09 | 934 | 99 | 16 | 33916271 |
| Pubmed | 1.06e-08 | 212 | 99 | 9 | 23463506 | ||
| Pubmed | 1.18e-08 | 55 | 99 | 6 | 9439656 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FAM193B MYCBP2 ESYT1 FGFRL1 ITGB4 GGA3 NHSL1 MSX2 GDPD5 ZNF296 NUAK1 AHNAK BRD4 NAV2 MLLT1 COBL AHNAK2 | 1.44e-08 | 1105 | 99 | 17 | 35748872 |
| Pubmed | Regulation of error-prone translesion synthesis by Spartan/C1orf124. | 1.82e-08 | 59 | 99 | 6 | 23254330 | |
| Pubmed | RPL23A H2BC11 ACLY CHD9 SRPK1 NCL H2BC18 YTHDF1 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF DYNC1LI1 H2BC12 | 2.68e-08 | 1153 | 99 | 17 | 29845934 | |
| Pubmed | RPL23A H2BC11 MYO5A MYCBP2 ACLY CKAP5 SRPK1 NCL ADNP NSUN2 H2BC13 CTCF AHNAK | 4.52e-08 | 653 | 99 | 13 | 22586326 | |
| Pubmed | H2BC11 SPANXA1 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 5.20e-08 | 438 | 99 | 11 | 21630459 | |
| Pubmed | 6.05e-08 | 14 | 99 | 4 | 10064132 | ||
| Pubmed | VAPA RPL23A MYCBP2 ACLY ESYT1 CKAP5 CHD9 SRPK1 NCL NSUN2 YARS1 H2BC14 AHNAK DYNC1LI1 | 7.43e-08 | 809 | 99 | 14 | 32129710 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZMYM2 NCL ADNP H2BC18 H2BC12L YTHDF1 H2BC13 H2BC14 H2BC9 CTCF AHNAK BRD4 MLLT1 DGCR8 H2BC12 | 8.46e-08 | 954 | 99 | 15 | 36373674 |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 8.93e-08 | 4 | 99 | 3 | 19091768 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | VAPA RPL23A H2BC11 LIMA1 MYO5A ACLY ESYT1 CKAP5 SRPK1 NCL ADNP NSUN2 ITGB4 YARS1 AHNAK CDC20 H2BC12 | 9.27e-08 | 1257 | 99 | 17 | 36526897 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | VAPA RPL23A H2BC11 LIMA1 CKAP5 SRPK1 NCL YTHDF1 H2BC13 H2BC14 H2BC4 H2BC17 DYNC1LI1 H2BC12 | 1.30e-07 | 847 | 99 | 14 | 35235311 |
| Pubmed | VAPA RPL23A ESYT1 NCL NSUN2 YARS1 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 | 1.64e-07 | 491 | 99 | 11 | 22623428 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | H2BC11 ZMYM2 CHD9 YARS1 H2BC17 CTCF AHNAK BRD4 DYNC1LI1 H2BC12 | 1.98e-07 | 394 | 99 | 10 | 27248496 |
| Pubmed | VAPA MYO5A ESYT1 SLC39A11 CKAP5 ZMYM2 ZNF622 SRPK1 ZHX2 JARID2 H2BC13 H2BC21 MICALL2 CTCF NFIB MLLT1 DGCR8 SPTY2D1 | 2.12e-07 | 1497 | 99 | 18 | 31527615 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 2.23e-07 | 5 | 99 | 3 | 17855024 | |
| Pubmed | Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. | 4.45e-07 | 6 | 99 | 3 | 22967069 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | VAPA RPL23A LIMA1 ESYT1 CKAP5 SIRPA GGA3 NHSL1 AHNAK NAV2 SNX2 | 6.55e-07 | 565 | 99 | 11 | 25468996 |
| Pubmed | The activity-dependent histone variant H2BE modulates the life span of olfactory neurons. | 7.77e-07 | 7 | 99 | 3 | 23240083 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.90e-06 | 202 | 99 | 7 | 33005030 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | VAPA H2BC11 MYLK SRPK1 ADNP MAP3K4 KSR1 H2BC17 H2BC21 NUAK1 PAK3 MLLT1 CDC20 | 1.92e-06 | 910 | 99 | 13 | 36736316 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL23A H2BC11 LIMA1 MYO5A ACLY NCL NSUN2 JPH1 H2BC4 H2BC21 AHNAK CDC20 H2BC12 | 3.04e-06 | 949 | 99 | 13 | 36574265 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VAPA RPL23A CKAP5 ZMYM2 NCL ADNP H2BC14 H2BC9 CTCF NFIB AHNAK BRD4 MLLT1 SPTY2D1 H2BC12 | 3.84e-06 | 1294 | 99 | 15 | 30804502 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.85e-06 | 440 | 99 | 9 | 34244565 | |
| Pubmed | 5.48e-06 | 88 | 99 | 5 | 26318153 | ||
| Pubmed | VAPA RPL23A H2BC11 ACLY ESYT1 CKAP5 NCL NSUN2 YARS1 AHNAK H2BC12 | 5.65e-06 | 707 | 99 | 11 | 19738201 | |
| Pubmed | An 'equalized cDNA library' by the reassociation of short double-stranded cDNAs. | 6.27e-06 | 13 | 99 | 3 | 2216762 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL23A MYO5A MYCBP2 ACLY ESYT1 CKAP5 SRPK1 NCL ADNP NSUN2 H2BC12L AHNAK DYNC1LI1 CDC20 AHNAK2 | 6.57e-06 | 1353 | 99 | 15 | 29467282 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO5A MYCBP2 ACLY CKAP5 ANKRD26 ZNF622 YTHDF1 AHNAK SECISBP2 CDC20 AHNAK2 | 7.07e-06 | 724 | 99 | 11 | 36232890 |
| Pubmed | 7.15e-06 | 247 | 99 | 7 | 30713523 | ||
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 7.96e-06 | 14 | 99 | 3 | 17662146 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 21297165 | ||
| Pubmed | BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK. | 8.02e-06 | 2 | 99 | 2 | 31110158 | |
| Pubmed | Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. | 8.02e-06 | 2 | 99 | 2 | 21964340 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 30568163 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 15007166 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 20833135 | ||
| Pubmed | ADNP modulates SINE B2-derived CTCF-binding sites during blastocyst formation in mice. | 8.02e-06 | 2 | 99 | 2 | 38479840 | |
| Pubmed | 9.20e-06 | 360 | 99 | 8 | 33111431 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL23A MYO5A MYCBP2 CKAP5 ZNF622 SRPK1 NCL NSUN2 H2BC18 DGCR8 SPTY2D1 | 1.10e-05 | 759 | 99 | 11 | 35915203 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.21e-05 | 268 | 99 | 7 | 33024031 | |
| Pubmed | VAPA RPL23A H2BC11 NCL ADNP H2BC12L H2BC13 AHNAK H2BC19P H2BC12 | 1.74e-05 | 652 | 99 | 10 | 31180492 | |
| Pubmed | LIMA1 ARHGAP24 MYO5A MYCBP2 MAP6 CKAP5 ZMYM2 NCL SIRPA ADNP CTCF PAK3 | 1.92e-05 | 963 | 99 | 12 | 28671696 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RPL23A MYCBP2 ACLY ESYT1 NCL NSUN2 H2BC18 H2BC13 AHNAK HYDIN AHNAK2 | 1.94e-05 | 807 | 99 | 11 | 30575818 |
| Pubmed | 2.10e-05 | 19 | 99 | 3 | 16522924 | ||
| Pubmed | 2.25e-05 | 295 | 99 | 7 | 26209609 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL23A LIMA1 MYO5A MYCBP2 ACLY CKAP5 NCL NSUN2 YARS1 H2BC4 AHNAK DYNC1LI1 SNX2 | 2.33e-05 | 1149 | 99 | 13 | 35446349 |
| Pubmed | 2.40e-05 | 298 | 99 | 7 | 30737378 | ||
| Pubmed | Nucleolin is a histone chaperone with FACT-like activity and assists remodeling of nucleosomes. | 2.40e-05 | 3 | 99 | 2 | 16601700 | |
| Pubmed | LUZP1 and the tumor suppressor EPLIN modulate actin stability to restrict primary cilia formation. | 2.40e-05 | 3 | 99 | 2 | 32496561 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 9582374 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 21940993 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL23A ACLY ESYT1 ZMYM2 NCL ADNP NSUN2 CTCF AHNAK DGCR8 CDC20 SPTY2D1 | 2.50e-05 | 989 | 99 | 12 | 36424410 |
| Pubmed | 2.77e-05 | 205 | 99 | 6 | 27976729 | ||
| Pubmed | 2.85e-05 | 206 | 99 | 6 | 22174317 | ||
| Pubmed | RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma. | 3.04e-05 | 62 | 99 | 4 | 35568845 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL23A LIMA1 MYO5A MYCBP2 ACLY CKAP5 NCL ADNP NSUN2 H2BC21 AHNAK SNX2 | 3.50e-05 | 1024 | 99 | 12 | 24711643 |
| Pubmed | 3.50e-05 | 565 | 99 | 9 | 20458337 | ||
| Pubmed | PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. | 3.65e-05 | 130 | 99 | 5 | 26598620 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 3.70e-05 | 569 | 99 | 9 | 30639242 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | VAPA RPL23A ESYT1 SLC39A11 CKAP5 ZMYM2 FGFRL1 NCL SIRPA CTCF AHNAK BRD4 CDC20 | 3.74e-05 | 1203 | 99 | 13 | 29180619 |
| Pubmed | 3.92e-05 | 441 | 99 | 8 | 31239290 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 4.29e-05 | 580 | 99 | 9 | 35676659 | |
| Pubmed | 4.32e-05 | 222 | 99 | 6 | 37071664 | ||
| Pubmed | A novel divergently transcribed human histone H2A/H2B gene pair. | 4.79e-05 | 4 | 99 | 2 | 1768865 | |
| Interaction | HMGN3 interactions | H2BC11 SRPK1 H2BC18 MSX2 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H2BC12 | 1.58e-16 | 64 | 95 | 12 | int:HMGN3 |
| Interaction | CDK5R2 interactions | 8.35e-14 | 23 | 95 | 8 | int:CDK5R2 | |
| Interaction | TNN interactions | 8.35e-14 | 23 | 95 | 8 | int:TNN | |
| Interaction | H2BC13 interactions | H2BC11 ARHGAP24 CKAP5 NCL H2BC18 JARID2 ZNF469 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.12e-12 | 210 | 95 | 14 | int:H2BC13 |
| Interaction | CYLC1 interactions | 3.05e-12 | 20 | 95 | 7 | int:CYLC1 | |
| Interaction | H2BC11 interactions | H2BC11 ARHGAP24 CKAP5 ADNP H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H2BC12 | 4.17e-12 | 186 | 95 | 13 | int:H2BC11 |
| Interaction | H2BC12 interactions | H2BC11 ARHGAP24 CKAP5 NCL H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AHNAK BRD4 PAK3 H2BC12 | 2.85e-11 | 322 | 95 | 15 | int:H2BC12 |
| Interaction | LOC102724334 interactions | RPL23A H2BC11 ARHGAP24 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 3.60e-11 | 134 | 95 | 11 | int:LOC102724334 |
| Interaction | HMGN4 interactions | H2BC11 H2BC18 H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 BRD4 H2BC12 PMAIP1 | 4.07e-11 | 100 | 95 | 10 | int:HMGN4 |
| Interaction | H2BC5 interactions | VAPA H2BC11 ARHGAP24 CKAP5 NCL H2BC18 MSX2 JARID2 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 4.20e-11 | 331 | 95 | 15 | int:H2BC5 |
| Interaction | H2BC26 interactions | H2BC11 ARHGAP24 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MICALL2 BRD4 H2BC12 | 6.21e-11 | 183 | 95 | 12 | int:H2BC26 |
| Interaction | DUOX2 interactions | 7.70e-11 | 30 | 95 | 7 | int:DUOX2 | |
| Interaction | H2AC7 interactions | H2BC11 ESYT1 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 8.05e-11 | 107 | 95 | 10 | int:H2AC7 |
| Interaction | MCM5 interactions | H2BC11 ARHGAP24 CKAP5 NCL H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H2BC20P H2BC19P H2BC12 | 1.17e-10 | 420 | 95 | 16 | int:MCM5 |
| Interaction | TEX35 interactions | 2.47e-10 | 57 | 95 | 8 | int:TEX35 | |
| Interaction | H2BC9 interactions | RPL23A H2BC11 ARHGAP24 CKAP5 H2BC18 ZNF469 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AHNAK BRD4 FGD6 H2BC12 | 2.82e-10 | 446 | 95 | 16 | int:H2BC9 |
| Interaction | PSMD14 interactions | H2BC11 ACLY ZMYM2 NCL NSUN2 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MICALL2 BRD4 H2BC12 AHNAK2 | 3.77e-10 | 527 | 95 | 17 | int:PSMD14 |
| Interaction | HMGN2 interactions | RPL23A H2BC11 YARS1 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 H2BC12 | 5.80e-10 | 222 | 95 | 12 | int:HMGN2 |
| Interaction | H2BC3 interactions | H2BC11 ARHGAP24 ZMYM2 CHD9 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AHNAK BRD4 CDC20 H2BC12 | 7.19e-10 | 406 | 95 | 15 | int:H2BC3 |
| Interaction | H2BC14 interactions | H2BC11 ARHGAP24 H2BC18 H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC12 | 1.04e-09 | 100 | 95 | 9 | int:H2BC14 |
| Interaction | H2BC17 interactions | H2BC11 ARHGAP24 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.16e-09 | 140 | 95 | 10 | int:H2BC17 |
| Interaction | ZNF474 interactions | 1.37e-09 | 44 | 95 | 7 | int:ZNF474 | |
| Interaction | H2AC14 interactions | VAPA H2BC11 H2BC18 H2BC14 H2BC9 H2BC17 H2BC21 BRD4 H2BC20P H2BC12 | 1.52e-09 | 144 | 95 | 10 | int:H2AC14 |
| Interaction | H2BC15 interactions | H2BC11 ARHGAP24 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.52e-09 | 144 | 95 | 10 | int:H2BC15 |
| Interaction | JPH2 interactions | 1.54e-09 | 25 | 95 | 6 | int:JPH2 | |
| Interaction | H2AC4 interactions | H2BC11 CHD9 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MICALL2 CTCF BRD4 LRRC27 DYNC1LI1 H2BC20P H2BC12 | 1.75e-09 | 506 | 95 | 16 | int:H2AC4 |
| Interaction | H2AZ1 interactions | VAPA H2BC11 ZMYM2 ADNP H2BC18 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 CTCF BRD4 H2BC20P H2BC12 | 2.13e-09 | 371 | 95 | 14 | int:H2AZ1 |
| Interaction | FAM47B interactions | 2.61e-09 | 13 | 95 | 5 | int:FAM47B | |
| Interaction | H2BC4 interactions | H2BC11 CKAP5 NCL H2BC18 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 PAK3 H2BC12 | 3.34e-09 | 259 | 95 | 12 | int:H2BC4 |
| Interaction | H2AC12 interactions | H2BC11 H2BC18 H2BC9 H2BC4 H2BC17 H2BC21 BRD4 SECISBP2 H2BC12 | 4.58e-09 | 118 | 95 | 9 | int:H2AC12 |
| Interaction | BTF3 interactions | VAPA RPL23A H2BC11 LIMA1 MYO5A CKAP5 NCL H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AHNAK BRD4 H2BC12 PMAIP1 | 4.95e-09 | 799 | 95 | 19 | int:BTF3 |
| Interaction | H2AC25 interactions | 5.87e-09 | 84 | 95 | 8 | int:H2AC25 | |
| Interaction | H3C1 interactions | H2BC11 ESYT1 ZMYM2 SRPK1 ADNP H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MICALL2 CTCF AHNAK BRD4 NAV2 MLLT1 CDC20 H2BC12 | 5.88e-09 | 901 | 95 | 20 | int:H3C1 |
| Interaction | ARHGAP24 interactions | H2BC11 LIMA1 ARHGAP24 ACLY SRPK1 NCL NSUN2 YARS1 H2BC18 H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 H2BC12 | 8.24e-09 | 486 | 95 | 15 | int:ARHGAP24 |
| Interaction | ADARB1 interactions | H2BC11 LIMA1 SRPK1 NCL H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF AHNAK SPTY2D1 H2BC12 | 8.95e-09 | 489 | 95 | 15 | int:ADARB1 |
| Interaction | H2BC18 interactions | H2BC11 ARHGAP24 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.32e-08 | 180 | 95 | 10 | int:H2BC18 |
| Interaction | H2AX interactions | RPL23A H2BC11 ZMYM2 NCL ADNP H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF MLLT1 H2BC20P H2BC12 | 1.66e-08 | 593 | 95 | 16 | int:H2AX |
| Interaction | TTN interactions | MYCBP2 NCL H2BC18 JPH1 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 MYOM2 H2BC12 MYBPC3 | 1.66e-08 | 299 | 95 | 12 | int:TTN |
| Interaction | CD81 interactions | VAPA RPL23A H2BC11 MYCBP2 NCL SIRPA H2BC18 H2BC13 H2BC14 H2BC9 H2BC17 H2BC12 | 1.93e-08 | 303 | 95 | 12 | int:CD81 |
| Interaction | RPS27A interactions | RPL23A H2BC11 ARHGAP24 NSUN2 H2BC18 GGA3 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MICALL2 BRD4 H2BC12 | 3.02e-08 | 536 | 95 | 15 | int:RPS27A |
| Interaction | DPPA2 interactions | 3.15e-08 | 40 | 95 | 6 | int:DPPA2 | |
| Interaction | YWHAH interactions | VAPA LIMA1 MYCBP2 ESYT1 CKAP5 ANKRD26 PITPNC1 NHSL1 KSR1 H2BC13 MAST4 NUAK1 AHNAK BRD4 NAV2 COBL CDC20 FGD6 SNX2 FAM110B AHNAK2 | 3.28e-08 | 1102 | 95 | 21 | int:YWHAH |
| Interaction | PCLO interactions | 3.89e-08 | 70 | 95 | 7 | int:PCLO | |
| Interaction | HCLS1 interactions | 4.30e-08 | 71 | 95 | 7 | int:HCLS1 | |
| Interaction | HMGN1 interactions | 9.98e-08 | 168 | 95 | 9 | int:HMGN1 | |
| Interaction | MCM2 interactions | VAPA RPL23A H2BC11 ARHGAP24 ACLY NCL YARS1 H2BC18 H2BC12L YTHDF1 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NUAK1 AHNAK BRD4 H2BC12 | 1.20e-07 | 1081 | 95 | 20 | int:MCM2 |
| Interaction | H2BC21 interactions | H2BC11 ARHGAP24 ZMYM2 NCL ADNP H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 AHNAK BRD4 MLLT1 H2BC12 | 1.50e-07 | 696 | 95 | 16 | int:H2BC21 |
| Interaction | H2BC1 interactions | H2BC11 ARHGAP24 H2BC18 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 1.64e-07 | 178 | 95 | 9 | int:H2BC1 |
| Interaction | IGSF8 interactions | RPL23A H2BC11 NCL H2BC18 GDPD5 H2BC13 H2BC14 H2BC9 H2BC17 H2BC12 | 1.91e-07 | 239 | 95 | 10 | int:IGSF8 |
| Interaction | YY1 interactions | RPL23A ZMYM2 NCL ZHX2 ADNP H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 CTCF BRD4 H2BC12 | 2.11e-07 | 454 | 95 | 13 | int:YY1 |
| Interaction | MACROH2A1 interactions | VAPA ZMYM2 ZNF622 SRPK1 NCL ADNP H2BC9 H2BC4 H2BC21 MICALL2 CTCF BRD4 H2BC12 | 2.34e-07 | 458 | 95 | 13 | int:MACROH2A1 |
| Interaction | YWHAG interactions | VAPA LIMA1 MYCBP2 ESYT1 CKAP5 ANKRD26 SRPK1 PITPNC1 NHSL1 KSR1 H2BC13 MAST4 NUAK1 NAV2 COBL CDC20 FGD6 SNX2 FAM110B AHNAK2 PSD4 | 2.68e-07 | 1248 | 95 | 21 | int:YWHAG |
| Interaction | H2AC11 interactions | H2BC11 H2BC18 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 AHNAK H2BC12 AHNAK2 | 2.69e-07 | 248 | 95 | 10 | int:H2AC11 |
| Interaction | RIOK1 interactions | RPL23A H2BC11 ACLY NCL NSUN2 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 PMAIP1 | 3.76e-07 | 562 | 95 | 14 | int:RIOK1 |
| Interaction | SFMBT2 interactions | 3.81e-07 | 32 | 95 | 5 | int:SFMBT2 | |
| Interaction | H2AC6 interactions | 4.63e-07 | 100 | 95 | 7 | int:H2AC6 | |
| Interaction | H2AC18 interactions | 4.96e-07 | 148 | 95 | 8 | int:H2AC18 | |
| Interaction | H3C15 interactions | 5.86e-07 | 207 | 95 | 9 | int:H3C15 | |
| Interaction | SERBP1 interactions | H2BC11 ACLY ESYT1 CKAP5 NCL NSUN2 YARS1 H2BC18 H2BC12L YTHDF1 MSX2 H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 MICALL2 CTCF BRD4 DYNC1LI1 SNX2 H2BC12 | 6.21e-07 | 1432 | 95 | 22 | int:SERBP1 |
| Interaction | PINK1 interactions | RPL23A H2BC11 LIMA1 ACLY NCL H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 AHNAK H2BC12 AHNAK2 | 6.36e-07 | 679 | 95 | 15 | int:PINK1 |
| Interaction | HMGA1 interactions | H2BC11 NCL H2BC18 MSX2 H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 BRD4 H2BC20P H2BC12 | 6.43e-07 | 419 | 95 | 12 | int:HMGA1 |
| Interaction | H2AB2 interactions | 7.34e-07 | 107 | 95 | 7 | int:H2AB2 | |
| Interaction | H1-10 interactions | 8.16e-07 | 280 | 95 | 10 | int:H1-10 | |
| Interaction | TOP3B interactions | H2BC11 FAM193B LIMA1 MYCBP2 ESYT1 FGFRL1 ITGB4 YARS1 GGA3 YTHDF1 NHSL1 MSX2 GDPD5 ZNF296 NUAK1 AHNAK BRD4 NAV2 SECISBP2 MLLT1 COBL AHNAK2 | 9.65e-07 | 1470 | 95 | 22 | int:TOP3B |
| Interaction | H3-4 interactions | H2BC11 NCL ADNP H2BC13 H2BC14 H2BC9 H2BC4 H2BC21 AHNAK MLLT1 H2BC20P H2BC12 | 1.30e-06 | 448 | 95 | 12 | int:H3-4 |
| Interaction | H2AC13 interactions | 1.45e-06 | 75 | 95 | 6 | int:H2AC13 | |
| Interaction | MAP1B interactions | H2BC11 ADNP NSUN2 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF H2BC12 | 1.46e-06 | 539 | 95 | 13 | int:MAP1B |
| Interaction | SIRT7 interactions | RPL23A H2BC11 MYO5A MYCBP2 ACLY CKAP5 SRPK1 NCL ADNP NSUN2 H2BC13 H2BC21 CTCF AHNAK BRD4 | 1.98e-06 | 744 | 95 | 15 | int:SIRT7 |
| Interaction | PDS5B interactions | 2.00e-06 | 178 | 95 | 8 | int:PDS5B | |
| Interaction | KMT2A interactions | RPL23A FGFRL1 NCL H2BC13 H2BC4 H2BC21 BRD4 MLLT1 CDC20 H2BC12 | 2.29e-06 | 314 | 95 | 10 | int:KMT2A |
| Interaction | MYH9 interactions | LIMA1 ARHGAP24 MYLK MYO5A CHD9 NCL H2BC9 H2BC4 CTCF AHNAK BRD4 COBL MYOM2 H2BC12 MYBPC3 | 2.34e-06 | 754 | 95 | 15 | int:MYH9 |
| Interaction | H1-4 interactions | RPL23A LIMA1 ARHGAP24 SRPK1 NCL H2BC18 YTHDF1 MSX2 H2BC9 H2BC21 CTCF BRD4 SPTY2D1 H2BC12 | 2.34e-06 | 656 | 95 | 14 | int:H1-4 |
| Interaction | YWHAZ interactions | VAPA LIMA1 MYO5A MYCBP2 MAP6 ESYT1 CKAP5 ANKRD26 PITPNC1 ZHX2 MAP3K4 NHSL1 MSX2 KSR1 MAST4 BRD4 NAV2 DYNC1LI1 FGD6 PSD4 | 2.73e-06 | 1319 | 95 | 20 | int:YWHAZ |
| Interaction | CKAP5 interactions | H2BC11 ACLY CKAP5 H2BC13 H2BC9 H2BC4 NUAK1 BRD4 DYNC1LI1 H2BC12 | 2.87e-06 | 322 | 95 | 10 | int:CKAP5 |
| Interaction | NAA40 interactions | FAM193B LIMA1 ACLY ESYT1 CKAP5 ANKRD26 ZMYM2 ZNF622 NCL ADNP NSUN2 GGA3 H2BC13 H2BC21 CTCF AHNAK AHNAK2 | 2.87e-06 | 978 | 95 | 17 | int:NAA40 |
| Interaction | ICAM1 interactions | 2.99e-06 | 252 | 95 | 9 | int:ICAM1 | |
| Interaction | EIF4B interactions | RPL23A ARHGAP24 NCL H2BC18 H2BC13 H2BC9 H2BC4 H2BC17 BRD4 DYNC1LI1 H2BC12 | 3.02e-06 | 402 | 95 | 11 | int:EIF4B |
| Interaction | WDR5 interactions | VAPA RPL23A H2BC11 MYLK ACLY ESYT1 ZMYM2 ZNF622 FGFRL1 NCL ADNP NSUN2 YARS1 H2BC21 CTCF BRD4 MLLT1 CDC20 | 3.33e-06 | 1101 | 95 | 18 | int:WDR5 |
| Interaction | ELK4 interactions | 4.81e-06 | 92 | 95 | 6 | int:ELK4 | |
| Interaction | MAPK7 interactions | 5.13e-06 | 143 | 95 | 7 | int:MAPK7 | |
| Interaction | ZNF469 interactions | 5.59e-06 | 8 | 95 | 3 | int:ZNF469 | |
| Interaction | TMEM196 interactions | 5.59e-06 | 8 | 95 | 3 | int:TMEM196 | |
| Interaction | TOP2A interactions | H2BC11 CKAP5 SRPK1 H2BC18 MAP3K4 H2BC13 H2BC9 H2BC17 H2BC21 CTCF BRD4 H2BC12 | 6.00e-06 | 520 | 95 | 12 | int:TOP2A |
| Interaction | OSBPL9 interactions | 6.16e-06 | 96 | 95 | 6 | int:OSBPL9 | |
| Interaction | UBA52 interactions | H2BC11 ARHGAP24 NCL H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC12 | 6.68e-06 | 437 | 95 | 11 | int:UBA52 |
| Interaction | MYH10 interactions | ARHGAP24 ESYT1 NCL H2BC13 H2BC14 H2BC9 H2BC4 CTCF BRD4 H2BC12 | 7.49e-06 | 359 | 95 | 10 | int:MYH10 |
| Interaction | CHMP4B interactions | RPL23A H2BC11 LIMA1 MYCBP2 ESYT1 CKAP5 NCL NSUN2 H2BC4 CTCF AHNAK COBL H2BC12 AHNAK2 | 7.63e-06 | 727 | 95 | 14 | int:CHMP4B |
| Interaction | TOMM70 interactions | 8.00e-06 | 153 | 95 | 7 | int:TOMM70 | |
| Interaction | CTTN interactions | RPL23A ARHGAP24 MYLK MYO5A MYCBP2 ACLY CKAP5 YTHDF1 AHNAK BRD4 SNX2 | 8.81e-06 | 450 | 95 | 11 | int:CTTN |
| Interaction | H1-3 interactions | 9.57e-06 | 291 | 95 | 9 | int:H1-3 | |
| Interaction | NPM1 interactions | RPL23A MYO5A ZNF622 SRPK1 NCL NSUN2 GGA3 H2BC14 H2BC4 H2BC21 MICALL2 CTCF BRD4 ANKRD30A H2BC20P FGD6 SPTY2D1 AHNAK2 | 1.10e-05 | 1201 | 95 | 18 | int:NPM1 |
| Interaction | H1-5 interactions | RPL23A ANKRD26 NCL H2BC18 MSX2 H2BC13 H2BC9 H2BC21 MICALL2 BRD4 MLLT1 | 1.15e-05 | 463 | 95 | 11 | int:H1-5 |
| Interaction | H4C9 interactions | 1.22e-05 | 108 | 95 | 6 | int:H4C9 | |
| Interaction | HDAC2 interactions | LIMA1 MYCBP2 ZNF423 ZMYM2 NCL ZHX2 NSUN2 JARID2 H2BC13 H2BC14 H2BC21 AHNAK BRD4 CDC20 AHNAK2 | 1.22e-05 | 865 | 95 | 15 | int:HDAC2 |
| Interaction | PNN interactions | 1.29e-05 | 302 | 95 | 9 | int:PNN | |
| Interaction | EPHA3 interactions | 1.42e-05 | 111 | 95 | 6 | int:EPHA3 | |
| Interaction | H1-2 interactions | RPL23A ARHGAP24 NCL H2BC18 H2BC9 H2BC4 H2BC21 ZNF296 MICALL2 AHNAK BRD4 H2BC20P H2BC12 | 1.44e-05 | 666 | 95 | 13 | int:H1-2 |
| Interaction | H2AZ2 interactions | 1.47e-05 | 168 | 95 | 7 | int:H2AZ2 | |
| Interaction | H2AC21 interactions | 1.49e-05 | 234 | 95 | 8 | int:H2AC21 | |
| Interaction | EIF1AX interactions | 1.58e-05 | 113 | 95 | 6 | int:EIF1AX | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | 1.89e-06 | 378 | 100 | 8 | chr6p22 | |
| Cytoband | 6p22.1 | 1.57e-05 | 142 | 100 | 5 | 6p22.1 | |
| Cytoband | 1q21.2 | 1.84e-05 | 71 | 100 | 4 | 1q21.2 | |
| Cytoband | 17q11.2 | 1.83e-03 | 110 | 100 | 3 | 17q11.2 | |
| Cytoband | 22q11.21 | 1.88e-03 | 111 | 100 | 3 | 22q11.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 2.29e-03 | 419 | 100 | 5 | chr22q11 | |
| GeneFamily | Histones | H2BC11 H2BC18 H2BC12L H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC20P H2BC19P H2BC12 | 1.00e-14 | 116 | 66 | 12 | 864 |
| GeneFamily | Variable charge X/Y family | 1.95e-04 | 6 | 66 | 2 | 368 | |
| GeneFamily | Fibronectin type III domain containing | 2.95e-04 | 160 | 66 | 5 | 555 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 3.62e-04 | 8 | 66 | 2 | 658 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.34e-03 | 15 | 66 | 2 | 529 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.84e-03 | 161 | 66 | 4 | 593 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | 8.08e-07 | 200 | 97 | 8 | M9952 | |
| Coexpression | HADDAD_B_LYMPHOCYTE_PROGENITOR | 1.34e-06 | 290 | 97 | 9 | M939 | |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | 1.25e-05 | 382 | 97 | 9 | M38972 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 3.38e-05 | 164 | 97 | 6 | M13108 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | H2BC11 CKAP5 ANKRD26 SRPK1 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 MAST4 CTCF DGCR8 CDC20 | 4.25e-05 | 939 | 97 | 13 | M45768 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K1 | 9.11e-08 | 125 | 95 | 8 | facebase_RNAseq_e9.5_MandArch_2500_K1 | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | 2.95e-07 | 32 | 95 | 5 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | 1.01e-05 | 110 | 95 | 6 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | 1.55e-05 | 70 | 95 | 5 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | VAPA H2BC11 MAP6 DACT2 CKAP5 SRPK1 NCL H2BC18 JARID2 H2BC13 H2BC14 H2BC17 PAK3 CDC20 TOX2 H2BC12 PMAIP1 | 2.17e-05 | 1202 | 95 | 17 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | 7.40e-05 | 50 | 95 | 4 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | MYLK MAP6 ZNF423 CKAP5 ZMYM2 SRPK1 NCL SIRPA H2BC18 JARID2 H2BC13 H2BC14 NAV2 DGCR8 TOX2 H2BC12 PMAIP1 | 9.02e-05 | 1347 | 95 | 17 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500 | MYO1G H2BC11 NCL ZHX2 NSUN2 FREM1 H2BC18 GGA3 JARID2 H2BC13 H2BC14 H2BC17 MICALL2 DYNC1LI1 CDC20 H2BC12 | 1.01e-04 | 1226 | 95 | 16 | facebase_RNAseq_e9.5_FaceMes_2500 |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-07 | 190 | 97 | 7 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-07 | 191 | 97 | 7 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | Control-Lymphocyte-B-Plasmablast|Control / Disease, Lineage and Cell Type | 1.50e-06 | 162 | 97 | 6 | 67b32c40cc180c5ebbfd901a417b5be469500110 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-06 | 171 | 97 | 6 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-06 | 178 | 97 | 6 | 39889db130216655a34796e7030ffeb372465500 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-06 | 188 | 97 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 3.65e-06 | 189 | 97 | 6 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-06 | 190 | 97 | 6 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 190 | 97 | 6 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.76e-06 | 190 | 97 | 6 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-06 | 190 | 97 | 6 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.88e-06 | 191 | 97 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-06 | 193 | 97 | 6 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 4.12e-06 | 193 | 97 | 6 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | Control-B_memory-3|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.37e-06 | 195 | 97 | 6 | 135234f068da3e8db7213b53c09ed6d1d0cdc351 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.37e-06 | 195 | 97 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.37e-06 | 195 | 97 | 6 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.37e-06 | 195 | 97 | 6 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 4.50e-06 | 196 | 97 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 4.50e-06 | 196 | 97 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Control-B_memory-3|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.63e-06 | 197 | 97 | 6 | b86385c6c1d52ef4e3d855004d77afab61556978 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, condition lineage and cell class | 4.91e-06 | 199 | 97 | 6 | 1b17e6d5e6b994dec65efae2667f4f1f438161b1 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.05e-06 | 200 | 97 | 6 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.05e-06 | 200 | 97 | 6 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.05e-06 | 200 | 97 | 6 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.05e-06 | 200 | 97 | 6 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.05e-06 | 200 | 97 | 6 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.07e-05 | 152 | 97 | 5 | 405d19b290232bb3e564d61c0cff0cfdd247bdff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.07e-05 | 152 | 97 | 5 | 06fa7d8acc8f56de00af9bee17884595b300410e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.13e-05 | 153 | 97 | 5 | b101cb1bce5db785dab46b6c4f7be9c3efe48b0e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.13e-05 | 153 | 97 | 5 | 487388082bb596809ba1caf9197626b6814792ab | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-dn_T|COVID-19_Severe / Disease group, lineage and cell class | 2.34e-05 | 156 | 97 | 5 | 83f25683e0f55472b56f915ee176fc05efc33a31 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-05 | 165 | 97 | 5 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.44e-05 | 169 | 97 | 5 | 88aa2246ede582c2e11de63228d76f520889ecb3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.44e-05 | 169 | 97 | 5 | a6a5b00912b653fad2ca7f096deaf35c9ef85e5b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.44e-05 | 169 | 97 | 5 | 42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f | |
| ToppCell | Healthy/Control-Plasmablast|World / Disease group and Cell class | 3.74e-05 | 172 | 97 | 5 | d3bfcf5d936152b71cd90f955f9331709edd979e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 174 | 97 | 5 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 174 | 97 | 5 | 723848d2f8ae9cf4f15d4b4a130f9a64dab443c7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 174 | 97 | 5 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | Healthy_donor-Plasmablast|World / disease group, cell group and cell class (v2) | 4.06e-05 | 175 | 97 | 5 | 5293e00fda63a291aa393bdf82ebd4b80265049f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-05 | 176 | 97 | 5 | 4ed73c73972334f6dc4229920205547823252fa0 | |
| ToppCell | Severe_COVID-19-Myeloid-Neutrophil|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.28e-05 | 177 | 97 | 5 | a6fae376f1beb1df423484d9b1bd1d954ca117af | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|tumor_Lung / Location, Cell class and cell subclass | 4.40e-05 | 178 | 97 | 5 | c57f92e57548638f1627dc7d313137f406dbecff | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.40e-05 | 178 | 97 | 5 | 850fcd368c4478c57eaedc74544773ea220f41f3 | |
| ToppCell | Healthy_donor-Plasmablast|Healthy_donor / disease group, cell group and cell class (v2) | 4.40e-05 | 178 | 97 | 5 | 388b8b4fa20dcc6e9ae4b06118e20b2c20c52bde | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.40e-05 | 178 | 97 | 5 | a16857da9f2907c176213a326112a1b4cbd0e628 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.52e-05 | 179 | 97 | 5 | ac987c9425a1b4106d1b8779a2c5461383eae2ae | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 4.52e-05 | 179 | 97 | 5 | 3fa75eec3e86fd1797eaa33362257df7f9b2a0bf | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.64e-05 | 180 | 97 | 5 | 1be264962fd4ed0bb59f9b8a6956c4239ca32e05 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.64e-05 | 180 | 97 | 5 | 5568063c2518fadb638e665635061ec10d00fb6a | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.02e-05 | 183 | 97 | 5 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 184 | 97 | 5 | 72b42dfca7e9c0257f11d8242531e843271871a7 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 184 | 97 | 5 | c6f4537ae8b6e8fde1be17df14629b7b49b4997c | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.15e-05 | 184 | 97 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.28e-05 | 185 | 97 | 5 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.28e-05 | 185 | 97 | 5 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | (2)_B_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.28e-05 | 185 | 97 | 5 | b0cbebe01b3c2e350d7ef2e6d269f2be6f3a152e | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.42e-05 | 186 | 97 | 5 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 187 | 97 | 5 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 187 | 97 | 5 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.56e-05 | 187 | 97 | 5 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 187 | 97 | 5 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.56e-05 | 187 | 97 | 5 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.56e-05 | 187 | 97 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 187 | 97 | 5 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 187 | 97 | 5 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.70e-05 | 188 | 97 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.70e-05 | 188 | 97 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.70e-05 | 188 | 97 | 5 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 5.85e-05 | 189 | 97 | 5 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 189 | 97 | 5 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 189 | 97 | 5 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 190 | 97 | 5 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-05 | 190 | 97 | 5 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.99e-05 | 190 | 97 | 5 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.99e-05 | 190 | 97 | 5 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.99e-05 | 190 | 97 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.99e-05 | 190 | 97 | 5 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.15e-05 | 191 | 97 | 5 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-05 | 191 | 97 | 5 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-05 | 191 | 97 | 5 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.15e-05 | 191 | 97 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 6.30e-05 | 192 | 97 | 5 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-05 | 192 | 97 | 5 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-05 | 192 | 97 | 5 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 6.30e-05 | 192 | 97 | 5 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-05 | 192 | 97 | 5 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.30e-05 | 192 | 97 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.30e-05 | 192 | 97 | 5 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-05 | 192 | 97 | 5 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-05 | 192 | 97 | 5 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.46e-05 | 193 | 97 | 5 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 6.46e-05 | 193 | 97 | 5 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | IPF-Endothelial-VE_Arterial|IPF / Disease state, Lineage and Cell class | 6.46e-05 | 193 | 97 | 5 | bf83b1fe9d38408f30eee4eb634341c04ef82791 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.46e-05 | 193 | 97 | 5 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.46e-05 | 193 | 97 | 5 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.46e-05 | 193 | 97 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | IPF-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 6.46e-05 | 193 | 97 | 5 | 70a9aadda83a97e06e9bc2d1327ce60dd3c58767 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.46e-05 | 193 | 97 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| Computational | Genes in the cancer module 89. | 1.09e-06 | 14 | 64 | 4 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 1.97e-06 | 16 | 64 | 4 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 2.57e-06 | 17 | 64 | 4 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 3.28e-06 | 18 | 64 | 4 | MODULE_552 | |
| Computational | Genes in the cancer module 534. | 3.28e-06 | 18 | 64 | 4 | MODULE_534 | |
| Computational | Genes in the cancer module 222. | 7.71e-06 | 22 | 64 | 4 | MODULE_222 | |
| Computational | Genes in the cancer module 168. | 7.71e-06 | 22 | 64 | 4 | MODULE_168 | |
| Computational | Genes in the cancer module 189. | 9.30e-06 | 23 | 64 | 4 | MODULE_189 | |
| Computational | Genes in the cancer module 127. | 1.55e-05 | 26 | 64 | 4 | MODULE_127 | |
| Computational | Chromatin. | 2.10e-05 | 28 | 64 | 4 | MODULE_421 | |
| Computational | rRNA processing and DNA repair. | 1.54e-04 | 18 | 64 | 3 | MODULE_392 | |
| Drug | Methylmethacrylate | 1.31e-08 | 39 | 95 | 6 | ctd:D020366 | |
| Drug | OTX015 | 4.98e-07 | 16 | 95 | 4 | ctd:C000605331 | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 4.49e-06 | 158 | 95 | 7 | 5743_UP | |
| Drug | ferric oxide | 1.31e-05 | 186 | 95 | 7 | ctd:C000499 | |
| Drug | Berberine | 2.23e-05 | 202 | 95 | 7 | ctd:D001599 | |
| Drug | Azacyclonol [115-46-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.60e-05 | 154 | 95 | 6 | 1520_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.21e-05 | 167 | 95 | 6 | 3979_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.46e-05 | 168 | 95 | 6 | 3395_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.96e-05 | 170 | 95 | 6 | 1050_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 8.22e-05 | 171 | 95 | 6 | 1000_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.22e-05 | 171 | 95 | 6 | 4954_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.49e-05 | 172 | 95 | 6 | 3428_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.49e-05 | 172 | 95 | 6 | 2330_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.49e-05 | 172 | 95 | 6 | 1637_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 8.49e-05 | 172 | 95 | 6 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.77e-05 | 173 | 95 | 6 | 5336_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.05e-05 | 174 | 95 | 6 | 3462_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 9.34e-05 | 175 | 95 | 6 | 1058_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.64e-05 | 176 | 95 | 6 | 6932_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 9.94e-05 | 177 | 95 | 6 | 6434_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.03e-04 | 178 | 95 | 6 | 1471_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.03e-04 | 178 | 95 | 6 | 992_DN | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.03e-04 | 178 | 95 | 6 | 6220_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.03e-04 | 178 | 95 | 6 | 1112_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 1.06e-04 | 179 | 95 | 6 | 332_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.06e-04 | 179 | 95 | 6 | 5484_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.09e-04 | 180 | 95 | 6 | 4541_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.12e-04 | 181 | 95 | 6 | 7005_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.16e-04 | 182 | 95 | 6 | 3887_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.23e-04 | 184 | 95 | 6 | 2321_DN | |
| Disease | Nephroblastoma | 5.04e-06 | 36 | 93 | 4 | C0027708 | |
| Disease | pain measurement | 9.77e-05 | 5 | 93 | 2 | EFO_0010639 | |
| Disease | Bilateral Wilms Tumor | 1.04e-04 | 29 | 93 | 3 | C2930471 | |
| Disease | neuroimaging measurement | FGFRL1 ZHX2 JPH1 NHSL1 MSX2 ZNF469 H2BC4 MAST4 NUAK1 NFIB NAV2 FGD6 | 1.34e-04 | 1069 | 93 | 12 | EFO_0004346 |
| Disease | cholesteryl ester 20:4 measurement | 3.66e-04 | 44 | 93 | 3 | EFO_0010348 | |
| Disease | Congenital hernia of foramen of Morgagni | 1.62e-03 | 19 | 93 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 1.62e-03 | 19 | 93 | 2 | C0265700 | |
| Disease | Craniosynostosis | 1.80e-03 | 20 | 93 | 2 | C0010278 | |
| Disease | Congenital diaphragmatic hernia | 1.98e-03 | 21 | 93 | 2 | C0235833 | |
| Disease | age at menopause | 2.71e-03 | 302 | 93 | 5 | EFO_0004704 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGSDPKRPEMPSKKP | 686 | P23470 | |
| KAVPLNASKQDGPMP | 146 | Q9P0L0 | |
| IAPKPQDKKSMGLPP | 271 | Q9H2P0 | |
| APARKNHKKMPVPPG | 211 | A0A494C0N9 | |
| PLKKGNKEPNPMVQL | 491 | Q9BSJ8 | |
| KAKEAAGPAPSPMRA | 31 | Q12834 | |
| NAEKVVGNMKPPKPT | 241 | P49711 | |
| SNVSKKEPAPMKSKP | 581 | O60885 | |
| PPKKPSAFKPAIEMQ | 516 | Q9BXX3 | |
| ECPDAKLKGPKFKMP | 1966 | Q09666 | |
| ECPDAKLKGPKFKMP | 2161 | Q09666 | |
| EGPDAKLKGPKFKMP | 3196 | Q09666 | |
| GPDAKLKGPKLKMPD | 3271 | Q09666 | |
| EGPDAKLKGPKFKMP | 4826 | Q09666 | |
| PSGPGVQDCMKKLKP | 96 | Q16663 | |
| SLANPGLMKEEPTKP | 351 | Q9UPS8 | |
| KKPKMSIVASAQPGG | 751 | Q8WYQ5 | |
| MPEPAKSAPAPKKGS | 1 | P57053 | |
| MKKPEKPLFSSASPQ | 316 | O00712 | |
| MAKDSPSPLGASPKK | 1 | A6NNM3 | |
| MAKDSPSPLGASPKK | 1 | A6NJZ7 | |
| MPEPAKSAPAPKKGS | 1 | Q16778 | |
| MPDPAKSAPAPKKGS | 1 | Q5QNW6 | |
| MPEPAKSAPAPKKGS | 1 | P06899 | |
| PAPGKQKKPNAMGLA | 201 | O60393 | |
| SKKDGVCGPPPSKKM | 496 | Q08J23 | |
| SSKPLPMAPEEKNKK | 31 | O75914 | |
| QMPAKKPKRGVPTSA | 1496 | Q14667 | |
| PAETLKPMGNAKPAE | 1031 | Q15746 | |
| AKPAETLKPMGNAKP | 1041 | Q15746 | |
| PPKNQSPMVPAKVKD | 536 | Q96JE9 | |
| SESSPPKAMKKFQAP | 371 | Q9UHB6 | |
| MPEPVKSAPVPKKGS | 1 | Q99879 | |
| MPEPAKFAPAPKKGS | 1 | Q6DN03 | |
| MPEPAKFAPAPKKGS | 1 | Q6DRA6 | |
| NKPLMSKAPTKEAGA | 511 | Q9HDC5 | |
| SPIPAGSKKIDPNMK | 421 | Q9Y6G9 | |
| MPDPAKSAPAPKKGS | 1 | Q93079 | |
| MPEPAKSAPAPKKGS | 1 | O60814 | |
| VPGGSVKPKIMSPEK | 831 | Q5SYE7 | |
| GSRPKPEAPMAKGKS | 551 | Q8IY33 | |
| PAAAARGPPKMADKV | 21 | Q8N441 | |
| LPKALTKKEHPPAMN | 426 | Q8IVT5 | |
| ITKPPQAGEIMKKPG | 561 | Q5H8C1 | |
| AAVPKSMKVKLQPPS | 646 | Q9NZ52 | |
| PCIMEKKDLGPKPAL | 216 | Q8WTR4 | |
| PIGPMKKVLVDNPKN | 1266 | P16144 | |
| KAGKNQGDPKKMAPP | 6 | P19338 | |
| PPLMVKKNPAFNKGS | 416 | Q8N264 | |
| MPEPAKSAPAPKKGS | 1 | P62807 | |
| MPGKKARKNAQPSPA | 1 | Q13794 | |
| AKVNMPAKPAPPTKA | 1076 | Q14008 | |
| SMKIKKNSAPLPGEQ | 661 | Q3L8U1 | |
| PMKKSQAANKQVPPL | 2376 | Q4G0P3 | |
| KAKPSPKASQMLPPD | 41 | Q53S99 | |
| PSFAASLKMGPPKSK | 481 | Q5SW24 | |
| GEKLPPDFMPKLVKN | 106 | Q96PV7 | |
| MAPKKKRGPSAGSQP | 1 | P0CW27 | |
| MPELAKSAPAPKKGS | 1 | Q99880 | |
| MPDPAKSAPAPKKGS | 1 | P23527 | |
| KMKARAPPPPGKAAT | 16 | O75128 | |
| KPPTEADKPNGMKRS | 2426 | O15021 | |
| PKPKIAAIASMKSPE | 226 | Q8TC76 | |
| MAKKQPACKTPGKPA | 1551 | Q9ULL0 | |
| AQMKPPKPTKSVGFE | 1641 | Q9ULL0 | |
| PPKAAFKEPKMALKE | 246 | Q03111 | |
| AQKNGKLPPADLKML | 306 | O15245 | |
| MKKKSDPEGPALLFP | 121 | Q8N1S5 | |
| EKPQSPPKKMKGAAG | 451 | Q92833 | |
| SPKLAASPMKKPFGF | 6 | Q6S8J7 | |
| ALMSDKKPPKEASPL | 51 | P35548 | |
| KMNAPNQPPHKDTGK | 116 | Q9Y6R4 | |
| IKMPINEPAPGKKKS | 236 | P32754 | |
| PPAPEKSIVGMTKVK | 206 | O60749 | |
| GDSDPQPAPKKMKTS | 31 | Q9NS26 | |
| KQKPMAKGPAKNSEP | 346 | P54577 | |
| MSPKPRASGPPAKAK | 1 | Q9H321 | |
| MSPKPRASGPPAKAK | 1 | O14598 | |
| PPGKMKPSKEKSPQA | 411 | Q9C0I9 | |
| MAKDSPSPLGASPKK | 1 | Q9UFD9 | |
| KKEPMAPSHSGIPKP | 576 | Q8IVL1 | |
| EKAQPSLPAGKMSKP | 751 | Q8NDX1 | |
| SKKPMLPAKFGQPQG | 456 | Q14190 | |
| DLNLPKGKKPAPQAA | 431 | P78324 | |
| NPLDSSAPLMKKGKQ | 506 | Q96T21 | |
| MSKAAPAKKPVAVAP | 1 | A0A087WV53 | |
| DGSKPLEPAKQAMSP | 3011 | O75592 | |
| PGKLSPKQSATMPKK | 451 | O60285 | |
| MAPKAKKEAPAPPKA | 1 | P62750 | |
| KKGMDFAPKDCPTPA | 191 | Q15477 | |
| VSTAPQPKPADKMSK | 251 | Q96SB4 | |
| TPVIMAKIKGPGPAK | 31 | Q8IXM7 | |
| PSSKGMPLPHAEKKS | 251 | Q68D10 | |
| PAKKAKPAMPQDSVP | 466 | P53396 | |
| PKFKMPSFGASAPGK | 1166 | Q8IVF2 | |
| PKLDLKGPKAEVMAP | 1766 | Q8IVF2 | |
| PKLDLKGPKTDVMAP | 2426 | Q8IVF2 | |
| PKLDLKGPKMDVTAP | 3251 | Q8IVF2 | |
| PKLDLKGPKADVMTP | 4241 | Q8IVF2 | |
| MPSFKVPKVDLKGPQ | 4386 | Q8IVF2 | |
| PKLDLKGPKAEVMAP | 4571 | Q8IVF2 | |
| STKPGFAMPKLALPK | 5016 | Q8IVF2 | |
| MAPKAAKGAKPEPAP | 1 | Q8TAZ6 | |
| MTSAAEIKKPPVAPK | 1 | Q6ZV73 | |
| LPDPEKKATLNLPGM | 306 | Q9UKF7 | |
| GTENGMKPATPKAKP | 3686 | Q96JG9 | |
| PPSPTPNKEMKNKAV | 836 | Q9UBW7 | |
| VSKTPIMKPGKPKAD | 181 | Q9Y6X8 | |
| KSTQANPPAKMLPPK | 311 | Q96NM4 | |
| IKAQPSMSPKKAPPA | 136 | Q969S3 | |
| SMSPKKAPPAPAKEA | 141 | Q969S3 | |
| TANGVPPMATKKAEP | 841 | Q2M1K9 | |
| PPMATKKAEPADLQG | 846 | Q2M1K9 | |
| AIASKPAKPQPKMKT | 236 | Q9BYJ9 | |
| PAKPQPKMKTKSGPV | 241 | Q9BYJ9 | |
| TDPANSQKASPKKMP | 361 | Q8WUU4 | |
| VKNIPPSDMPQIKAK | 801 | B0I1T2 | |
| PAKPTKGRPGQMAKE | 616 | Q9Y4I1 | |
| KIPDMAPPQQAKPKL | 1441 | P54296 | |
| MPEPGKKPVSAFSKK | 1 | Q14896 |